Purchase 500 million yuan worth of financial products from REMEGEN (09995).
Rongchang Biotechnology (09995) announced that on October 15, 2025, the company entered into an agreement with the Yantai Branch of Shanghai Pudong Development Bank...
REMEGEN (09995) announced that on October 15, 2025, the company entered into a Wealth Management Product Agreement with the Shanghai Pudong Development Bank Yantai Branch. According to this agreement, the company agreed to (1) use 400 million RMB of idle own funds to purchase wealth management products from the Shanghai Pudong Development Bank Yantai Branch, and (2) use 100 million RMB of idle raised funds to purchase wealth management products from the Shanghai Pudong Development Bank Yantai Branch.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
